Lanean...
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
OBJECTIVES: We evaluated the expression of human-trophoblast-cell-surface-marker (Trop-2) and the potential of hRS7, a humanized-monoclonal-anti-Trop-2-antibody, against treatment-refractory cervical cancer. STUDY DESIGN: Trop-2 expression was evaluated by immunohistochemistry (IHC), real-time polym...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3224189/ https://ncbi.nlm.nih.gov/pubmed/21889762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2011.06.093 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|